Baicalein prevents human prion protein-induced neuronal cell death by regulating JNK activation

Moon,Ji-Hong; Park,Sang-Youel

doi:10.3892/ijmm.2014.2010

Baicalein prevents human prion protein-induced neuronal cell death by regulating JNK activation

Authors:
- Ji-Hong Moon
- Sang-Youel Park
View Affiliations

Affiliations: Biosafety Research Institute, College of Veterinary Medicine, Chonbuk National University, Jeonju, Jeonbuk 561-756, Republic of Korea
Published online on: November 26, 2014 https://doi.org/10.3892/ijmm.2014.2010
Pages: 439-445

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Prion diseases are neurodegenerative disorders characterized by the accumulation of an abnormal isoform of the protease-insensitive isoform (PrPSc) of prion protein. Human prion protein fragment 106‑126 [PrP (106‑126)] contains most of the pathological characteristics associated with PrPSc. Although a number of compounds have been identified to inhibit PrP accumulation or dissolve fibrils and aggregates in vitro, there is currenlty no treatment available for these progressive neurodegenerative diseases. Baicalein, the dried root of Scutellaria baicalensis (S. baicalensis) Georgi (known as Huang-qin in traditional Chinese medicine) has been reported to exert neuroprotective effects on neurodegenerative diseases. In the present study, we investigated the effects of baicalein on the development of prion diseases using SH-SY5Y and SK-N-SH cells in vitro. We found that baicalein protected the cells against PrP‑induced neuronal cell death by inhibiting the production of reactive oxygen species (ROS) and mitochondrial dysfunction using ROS detection assay and MTP assay. We demonstrated that baicalein treatment regulated the phosphorylation of c-Jun N-terminal kinase (JNK) by using western blot analysis and Annexin V assay. Our data suggest that baicalein has potential for use as a therapeutic drug for the treatment of various neurodegenerative diseases, including prion diseases.

View Figures

View References

1	Peretz D, Williamson RA, Kaneko K, et al: Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature. 412:739–743. 2001. View Article : Google Scholar : PubMed/NCBI
2	Aguzzi A: Prion diseases of humans and farm animals: epidemiology, genetics, and pathogenesis. J Neurochem. 97:1726–1739. 2006. View Article : Google Scholar : PubMed/NCBI
3	Caughey B, Raymond GJ, Ernst D and Race RE: N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state. J Virol. 65:6597–6603. 1991.PubMed/NCBI
4	Selvaggini C, De Gioia L, Cantu L, et al: Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106–126 of the prion protein. Biochem Biophys Res Commun. 194:1380–1386. 1993. View Article : Google Scholar : PubMed/NCBI
5	Forloni G, Angeretti N, Chiesa R, et al: Neurotoxicity of a prion protein fragment. Nature. 362:543–546. 1993. View Article : Google Scholar : PubMed/NCBI
6	Florio T, Grimaldi M, Scorziello A, et al: Intracellular calcium rise through L-type calcium channels, as molecular mechanism for prion protein fragment 106–126-induced astroglial proliferation. Biochem Biophys Res Commun. 228:397–405. 1996. View Article : Google Scholar : PubMed/NCBI
7	De Gioia L, Selvaggini C, Ghibaudi E, et al: Conformational polymorphism of the amyloidogenic and neurotoxic peptide homologous to residues 106–126 of the prion protein. J Biol Chem. 269:7859–7862. 1994.PubMed/NCBI
8	Corsaro A, Thellung S, Villa V, et al: Prion protein fragment 106–126 induces a p38 MAP kinase-dependent apoptosis in SH-SY5Y neuroblastoma cells independently from the amyloid fibril formation. Ann N Y Acad Sci. 1010:610–622. 2003. View Article : Google Scholar
9	Halliwell B: Oxidative stress and neurodegeneration: where are we now? J Neurochem. 97:1634–1658. 2006. View Article : Google Scholar : PubMed/NCBI
10	Jabs T: Reactive oxygen intermediates as mediators of programmed cell death in plants and animals. Biochem Pharmacol. 57:231–245. 1999. View Article : Google Scholar : PubMed/NCBI
11	Scherz-Shouval R, Shvets E, Fass E, Shorer H, Gil L and Elazar Z: Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J. 26:1749–1760. 2007. View Article : Google Scholar : PubMed/NCBI
12	Borger E, Aitken L, Muirhead KE, et al: Mitochondrial β-amyloid in Alzheimer’s disease. Biochem Soc Trans. 39:868–873. 2011. View Article : Google Scholar : PubMed/NCBI
13	Coskun P, Wyrembak J, Schriner SE, et al: A mitochondrial etiology of Alzheimer and Parkinson disease. Biochim Biophys Acta. 1820:553–564. 2012. View Article : Google Scholar :
14	Siskova Z, Mahad DJ, Pudney C, et al: Morphological and functional abnormalities in mitochondria associated with synaptic degeneration in prion disease. Am J Pathol. 177:1411–1421. 2010. View Article : Google Scholar : PubMed/NCBI
15	O’Donovan CN, Tobin D and Cotter TG: Prion protein fragment PrP-(106–126) induces apoptosis via mitochondrial disruption in human neuronal SH-SY5Y cells. J Biol Chem. 276:43516–43523. 2001. View Article : Google Scholar
16	Shang YZ, Gong MY, Zhou XX, Li ST and Wang BY: Improving effects of SSF on memory deficits and pathological changes of neural and immunological systems in senescent mice. Acta Pharmacol Sin. 22:1078–1083. 2001.PubMed/NCBI
17	Shang Y, Cheng J, Qi J and Miao H: Scutellaria flavonoid reduced memory dysfunction and neuronal injury caused by permanent global ischemia in rats. Pharmacol Biochem Behav. 82:67–73. 2005. View Article : Google Scholar : PubMed/NCBI
18	Bochorakova H, Paulova H, Slanina J, Musil P and Taborska E: Main flavonoids in the root of Scutellaria baicalensis cultivated in Europe and their comparative antiradical properties. Phytother Res. 17:640–644. 2003. View Article : Google Scholar : PubMed/NCBI
19	Heo HJ, Kim DO, Choi SJ, Shin DH and Lee CY: Potent inhibitory effect of flavonoids in Scutellaria baicalensis on amyloid beta protein-induced neurotoxicity. J Agric Food Chem. 52:4128–4132. 2004. View Article : Google Scholar : PubMed/NCBI
20	Huang Y, Wong CM, Lau CW, et al: Inhibition of nitric oxide/cyclic GMP-mediated relaxation by purified flavonoids, baicalin and baicalein, in rat aortic rings. Biochem Pharmacol. 67:787–794. 2004. View Article : Google Scholar : PubMed/NCBI
21	Chen YC, Shen SC, Chen LG, Lee TJ and Yang LL: Wogonin, baicalin, and baicalein inhibition of inducible nitric oxide synthase and cyclooxygenase-2 gene expressions induced by nitric oxide synthase inhibitors and lipopolysaccharide. Biochem Pharmacol. 61:1417–1427. 2001. View Article : Google Scholar : PubMed/NCBI
22	Chang WS, Lee YJ, Lu FJ and Chiang HC: Inhibitory effects of flavonoids on xanthine oxidase. Anticancer Res. 13:2165–2170. 1993.PubMed/NCBI
23	Kyo R, Nakahata N, Sakakibara I, Kubo M and Ohizumi Y: Baicalin and baicalein, constituents of an important medicinal plant, inhibit intracellular Ca²⁺ elevation by reducing phospholipase C activity in C6 rat glioma cells. J Pharm Pharmacol. 50:1179–1182. 1998. View Article : Google Scholar : PubMed/NCBI
24	Liao JF, Hung WY and Chen CF: Anxiolytic-like effects of baicalein and baicalin in the Vogel conflict test in mice. Eur J Pharmacol. 464:141–146. 2003. View Article : Google Scholar : PubMed/NCBI
25	Yu X, He G and Du G: Neuroprotective effect of baicalein in patients with Parkinson’s disease. Zhongguo Zhong Yao Za Zhi. 37:421–425. 2012.in Chinese. PubMed/NCBI
26	Mu X, He GR, Yuan X, Li XX and Du GH: Baicalein protects the brain against neuron impairments induced by MPTP in C57BL/6 mice. Pharmacol Biochem Behav. 98:286–291. 2011. View Article : Google Scholar : PubMed/NCBI
27	Carimalo J, Cronier S, Petit G, et al: Activation of the JNK-c-Jun pathway during the early phase of neuronal apoptosis induced by PrP106–126 and prion infection. Eur J Neurosci. 21:2311–2319. 2005. View Article : Google Scholar : PubMed/NCBI
28	Lee E, Park HR, Ji ST, Lee Y and Lee J: Baicalein attenuates astroglial activation in the 1-methyl-4-phenyl-1,2,3,4-tetrahydro-pyridine-induced Parkinson’s disease model by downregulating the activations of nuclear factor-kappaB, ERK, and JNK. J Neurosci Res. 92:130–139. 2014. View Article : Google Scholar
29	Lee JH and Lee SR: The effect of baicalein on hippocampal neuronal damage and metalloproteinase activity following transient global cerebral ischaemia. Phytother Res. 26:1614–1619. 2012. View Article : Google Scholar : PubMed/NCBI
30	Liu C, Wu J, Xu K, et al: Neuroprotection by baicalein in ischemic brain injury involves PTEN/AKT pathway. J Neurochem. 112:1500–1512. 2010. View Article : Google Scholar : PubMed/NCBI
31	Kovacic P and Somanathan R: Redox processes in neurode-generative disease involving reactive oxygen species. Curr Neuropharmacol. 10:289–302. 2012. View Article : Google Scholar :
32	Chakraborty S, Bornhorst J, Nguyen TT and Aschner M: Oxidative stress mechanisms underlying Parkinson’s disease-associated neurodegeneration in C. elegans. Int J Mol Sci. 14:23103–23128. 2013. View Article : Google Scholar : PubMed/NCBI
33	Beal MF: Mitochondria take center stage in aging and neurode-generation. Ann Neurol. 58:495–505. 2005. View Article : Google Scholar : PubMed/NCBI
34	Radi R, Cassina A and Hodara R: Nitric oxide and peroxynitrite interactions with mitochondria. Biol Chem. 383:401–409. 2002. View Article : Google Scholar : PubMed/NCBI
35	Bolanos JP, Moro MA, Lizasoain I and Almeida A: Mitochondria and reactive oxygen and nitrogen species in neurological disorders and stroke: therapeutic implications. Adv Drug Deliv Rev. 61:1299–1315. 2009. View Article : Google Scholar : PubMed/NCBI
36	Choi JH, Choi AY, Yoon H, et al: Baicalein protects HT22 murine hippocampal neuronal cells against endoplasmic reticulum stress-induced apoptosis through inhibition of reactive oxygen species production and CHOP induction. Exp Mol Med. 42:811–822. 2010. View Article : Google Scholar : PubMed/NCBI
37	Shen HM and Liu ZG: JNK signaling pathway is a key modulator in cell death mediated by reactive oxygen and nitrogen species. Free Radic Biol Med. 40:928–939. 2006. View Article : Google Scholar : PubMed/NCBI
38	Sato M, Bagchi D, Tosaki A and Das DK: Grape seed proanthocyanidin reduces cardiomyocyte apoptosis by inhibiting ischemia/reperfusion-induced activation of JNK-1 and C-JUN. Free Radic Biol Med. 31:729–737. 2001. View Article : Google Scholar : PubMed/NCBI
39	Yoshizumi M, Kogame T, Suzaki Y, et al: Ebselen attenuates oxidative stress-induced apoptosis via the inhibition of the c-Jun N-terminal kinase and activator protein-1 signalling pathway in PC12 cells. Br J Pharmacol. 136:1023–1032. 2002. View Article : Google Scholar : PubMed/NCBI